Figure 3.

Forest plot showing the risk of death at 3, 6 and 12 months and 2 and 5 years and at final follow-up in patients treated with pulse or continuous cyclophosphamide. At no time point is there any significant difference between the treatment groups.

Walters et al. BMC Nephrology 2010 11:12   doi:10.1186/1471-2369-11-12
Download authors' original image